Ellume Founder and Managing Director Dr Sean Parsons
Brisbane medical diagnostics company Ellume has signed a significant deal with pharmaceutical giant GSK for digital consumer products, ahead of a potential market listing. Ellume founder and managing directory Sean Parsons said the global deal was the biggest of its kind in Australia.
“A GSK deal of this type is a pivotal change for a business like Ellume,” Dr Parsons said.
“It will enable the product to scale into a global market and it provides an external validation of the quality of the technology.”
The strategic partnership is with GSK’s consumer arm and is believed to be focused on respiratory care.
Dr Parsons said the company was focused on the US market, which had a reimbursement system and healthcare system that was set up for new technologies.
He added that Ellume retained the rights to secure a partnership with another company in a different healthcare space. He expected a new deal to be announced next month.
Dr Parsons, who trained in critical care, said the technology the company had created integrated a diagnosis and the tests made in that diagnosis, with a pathway for the best treatment for an illness.
“We have taken the approach in consumer products of solving one problem really well,” he said.
